HYDERABAD, India--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories (NYSE:RDY) has launched Levocetirizine tablets (5mg), a bioequivalent generic version of Xyzal® tablets in the US market.

Mylan announced the launch of the Montelukast Sodium Tablets and Chewable Tablets, the generic version of Merck‘s Singulair. Mylan has already begun shipping Montelukast Sodium Tablets 10mg and ...

Dr. Reddy's Levocetirizine Dihydrochloride tablets are available in 5 mg strength and several consumer oriented package sizes. As per IRI, an American market research Company, the Xyzal Allergy ...

Dr. Reddy’s Laboratories (RDY) has launched Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets, bioequivalent generic versions of SINGULAIR (MRK) Tablets and Chewable tablets ...

Dr Reddy's Laboratories today announced that it has launched Montelukast sodium tablets and Montelukast sodium chewable tablets in US market on Monday. Dr Reddy's Laboratories today announced that ...

HYDERABAD, India--(BUSINESS WIRE)-- Dr. Reddy's Laboratories (NYS: RDY) announced today that it has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair ...

Dr. Reddy’s Laboratories announced the launch of Montelukast Sodium Oral Granules, the generic version of Merck‘s Singulair oral granules. Montelukast Sodium, a leukotriene antagonist ...

Drug firm Dr Reddy's Laboratories said on Monday, it has launched levocetirizine tablets, which are used for relieving allergies, in the American market. The US Food and Drug Administration ...

NEW DELHI: Drug firm Dr Reddy's Laboratories has launched levocetirizine dihydrochloride tablets, used for relieving allergies, in the US market. In a BSE filing, Dr Reddy's Laboratories said it ...

Dr. Reddy’s Laboratories (RDY) has launched Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets, bioequivalent generic versions of SINGULAIR (MRK) Tablets and Chewable tablets ...

Dr. Reddy's Announces the Launch of Montelukast Sodium Oral Granules HYDERABAD, India--(BUSINESS WIRE)-- Dr. Reddy's Laboratories (NYS: RDY) announced today that it has launched Montelukast Sodium ...

Dr. Reddy’s Laboratories Ltd has launched Levocetirizine Dihydrochloride tablets, an over-the-counter therapeutic equivalent generic version of Xyzal Allergy 24HR tablets, in the US market.